Mammen Mathai

Officer at TXG; SVP, Research & Early Clin Dev at INVA

Sold, on record
$4.7M
Dollars the filings state
Form 4 sales
9
Latest May 11, 2023
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • TXG10x Genomics, Inc.Officer
  • INVAInnoviva, Inc.SVP, Research & Early Clin Dev

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale INVAPlan not stated
    Aug 13, 2012 2012

    Sold 25,000 shares at $25.74 ($643k)

    Mammen Mathai, SVP, Research & Early Clin Dev

    Sold 10.5% of holdings ($6.1M position)212,285 shares leftFiling

  2. 2 Form 4 sale INVAPlan not stated
    Nov 2, 2012 +81 days

    Sold 7,000 shares at $21.45 ($150k)

    Mammen Mathai, SVP, Research & Early Clin Dev

    Sold 3.3% of holdings ($4.6M position)205,641 shares leftFiling

  3. 3 Form 4 sale INVAPlan not stated
    Feb 20, 2013 +110 days

    Sold 7,000 shares at $22.14 ($155k)

    Mammen Mathai, SVP, Research & Early Clin Dev

    Sold 3.2% of holdings ($4.9M position)212,976 shares leftFiling

  4. 4 Form 4 sale INVAPlan not stated
    Apr 30, 2013 +69 days

    Sold 7,000 shares at $33.74 ($236k)

    Mammen Mathai, SVP, Research & Early Clin Dev

    Sold 3.3% of holdings ($7.2M position)205,976 shares left1x usual sizeFiling

  5. 5 Form 4 sale INVAPlan not stated
    Jul 30, 2013 +91 days

    Sold 7,000 shares at $36.51 ($256k)

    Mammen Mathai, SVP, Research & Early Clin Dev

    Sold 3.2% of holdings ($8M position)211,705 shares left1x usual sizeFiling

  6. 6 Form 4 sale INVAUnusual
    Feb 14, 2014 +199 days

    Sold 35,000 shares at $39.36 ($1.4M)

    Mammen Mathai, SVP, Research & Early Clin Dev

    Sold 15.8% of holdings ($8.7M position)186,623 shares left5x usual sizeFiling

  7. 7 Form 144 notice TXGNotice
    May 11, 2023 +3373 days

    Filed to sell 33,000 shares ($1.8M)

    Mammen Mathai, Officer

    No 10b5-1 planFirst sale on recordFiling

  8. 8 Form 4 sale TXGNo plan
    May 11, 2023 same day

    Sold 33,000 shares at $52.82 ($1.7M)

    Mammen Mathai, Director

    No 10b5-1 planSold 16.3% of holdings ($10.7M position)169,745 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Mammen Mathai
Source
May 11, 2023May 15, 2023TXGDirectorForm 4 sale33,000$1.7M16.3%No planSEC
May 11, 2023May 11, 2023TXGOfficerForm 144 notice33,000$1.8MNoticeSEC
Feb 14, 2014Feb 19, 2014INVASVP, Research & Early Clin DevForm 4 sale35,000$1.4M15.8%UnusualSEC
Jul 30, 2013Aug 1, 2013INVASVP, Research & Early Clin DevForm 4 sale7,000$256k3.2%Plan not statedSEC
Apr 30, 2013May 2, 2013INVASVP, Research & Early Clin DevForm 4 sale7,000$236k3.3%Plan not statedSEC
Feb 20, 2013Feb 22, 2013INVASVP, Research & Early Clin DevForm 4 sale7,000$155k3.2%Plan not statedSEC
Nov 2, 2012Nov 6, 2012INVASVP, Research & Early Clin DevForm 4 sale7,000$150k3.3%Plan not statedSEC
Aug 13, 2012Aug 15, 2012INVASVP, Research & Early Clin DevForm 4 sale25,000$643k10.5%Plan not statedSEC
Feb 18, 2011Feb 23, 2011INVASVP, Research & Early Clin DevForm 4 sale3,701$86k1.4%Plan not statedSEC
Sep 1, 2010Sep 2, 2010INVASVP, Research & Early Clin DevForm 4 sale4,416$57k3.6%Plan not statedSEC